RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Chembio Diagnostics Stock and on which exchange is it traded?
The symbol for Chembio Diagnostics is CEMI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Chembio Diagnostics Stock?
Chembio Diagnostics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Chembio Diagnostics Stock?
Chembio Diagnostics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Chembio Diagnostics Stock.

What's the current price of Chembio Diagnostics Stock?
As of the end of day on the Jul 26, 2023, the price of an Chembio Diagnostics (CEMI) share was $0.455.

What is the 52-week high and low for Chembio Diagnostics Stock?
The 52-week high for Chembio Diagnostics Stock is $1.24 and the 52-week low is $0.190.

What is the market capitalization of Chembio Diagnostics Stock?
As of the Jul 26, 2023, the market capitalization of Chembio Diagnostics is 16.71M.
Click to get the best stock tips daily for free!

About Chembio Diagnostics

Chembio Diagnostics Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products unde... CEMI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT